Immunotherapy News and Research

Latest Immunotherapy News and Research

DNA biomarker test helps predict recurrence of HPV-driven oropharyngeal cancer after treatment

DNA biomarker test helps predict recurrence of HPV-driven oropharyngeal cancer after treatment

MAIT cells exercise complex functions and may be targets for future immunotherapies and vaccines

MAIT cells exercise complex functions and may be targets for future immunotherapies and vaccines

AI model could be a low-cost, non-invasive option for thyroid cancer screening and staging

AI model could be a low-cost, non-invasive option for thyroid cancer screening and staging

Study demonstrates that TMPRSS2, which is key to SARS-CoV-2 cell entry, is a tumor suppressor

Study demonstrates that TMPRSS2, which is key to SARS-CoV-2 cell entry, is a tumor suppressor

Why is it Important to Democratize Proteomics Data?

Why is it Important to Democratize Proteomics Data?

New radio-labeled molecule may allow a non-invasive approach to monitor inflammation in real time

New radio-labeled molecule may allow a non-invasive approach to monitor inflammation in real time

T-cell responses linked with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer

T-cell responses linked with protection from SARS-CoV-2 infection in vaccinated individuals with or without cancer

Novel blood biomarkers can potentially predict melanoma patients' response to immunotherapy

Novel blood biomarkers can potentially predict melanoma patients' response to immunotherapy

Optical genome mapping holds potential to become an important component of leukemia diagnostics

Optical genome mapping holds potential to become an important component of leukemia diagnostics

Developing nanoplatforms for direct drug delivery to T cells

Developing nanoplatforms for direct drug delivery to T cells

Researchers find potential new strategy to treat metastatic form of intra-abdominal cancer

Researchers find potential new strategy to treat metastatic form of intra-abdominal cancer

Study finds mRNA vaccines induce poor neutralizing antibody response against SARS-CoV-2 variants in dialysis patients

Study finds mRNA vaccines induce poor neutralizing antibody response against SARS-CoV-2 variants in dialysis patients

Novel tool for better dietary management in cancer patients

Novel tool for better dietary management in cancer patients

Showcasing STEM Women in Medical Science

Showcasing STEM Women in Medical Science

New analysis highlights growing trends in combination cancer therapy clinical trials

New analysis highlights growing trends in combination cancer therapy clinical trials

New research confirms the safety of mRNA COVID-19 vaccines for people with cancer

New research confirms the safety of mRNA COVID-19 vaccines for people with cancer

Novel immune-profiling method offers a powerful alternative to conventional flow cytometry

Novel immune-profiling method offers a powerful alternative to conventional flow cytometry

Children’s National performs first-ever HIFU surgery on a pediatric patient with neurofibromatosis

Children’s National performs first-ever HIFU surgery on a pediatric patient with neurofibromatosis

Research findings provide a potential roadmap for metastatic tumor formation

Research findings provide a potential roadmap for metastatic tumor formation

Antibody drug improves survival rates in canine prostate cancer model

Antibody drug improves survival rates in canine prostate cancer model

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.